Topic: atrial fibrillation
Acutus Medical will acquire Rhythm Xience alongside a handful of new partnerships as expands its portfolio beyond its heart mapping platform.
AliveCor has secured an FDA clearance for its personal device offering six leads, providing more detailed views into heartbeats and arrhythmias.
The cryoablation therapy will featuring an integrated, real-time guidance system for the treatment of atrial fibrillation.
One of the splashier medtech moments of 2018 to come out of an FDA 510(k) decision was the agency’s de novo clearance of the latest Apple Watch and its software allowing on-demand electrocardiograms for the mass-market consumer.
AliveCor has secured two additional FDA clearances for its personal electrocardiogram, allowing it to detect bradycardia and tachycardia arrhythmias.
IRhythm’s ECG patch was able to improve atrial fibrillation diagnoses and lower numbers of ER visits by shifting patients to outpatient settings.
Canvassing more than 400,000 people in 8 months, Apple has finished an investigation of its smartwatch’s ability to detect irregular heart rhythms.
Medtronic has moved to buy EPIX Therapeutics and its RF cardiac ablation system with plans to build out its suite of heart arrhythmia treatments.
Apple and J&J are teaming up to see if the Apple Watch can help catch and diagnose seniors with atrial fibrillation earlier and faster than before.
The new Apple Watch’s electrocardiogram capability has gone live, available as a free software update that allows for wrist-based ECGs on the go.